The global healthcare industry continues to witness rising demand for anti-parasitic therapies due to the growing burden of infectious diseases such as malaria and toxoplasmosis. Pharmaceutical manufacturers are increasingly focusing on improving treatment accessibility, expanding drug delivery systems, and strengthening regional distribution networks to address unmet clinical needs....